Skip to main content

D. E. Shaw & Co., Inc.

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in AGIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$115,300,954
+$24,597,007 QoQ
Shares Held
3,107,005
+15.9% QoQ
Ownership
5.20%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#5
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Dec 31, 2025
CallValue
$656,002
CallShares
24,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. AGIO ranks #11 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGIO

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $115,300,954 3,107,005
2026-03-31 $90,703,947 2,681,169
2025-12-31 $656,002 24,100
2025-12-31 $50,008,202 1,837,186
2025-09-30 $14,761,443 367,749
2025-06-30 $19,829,678 596,202
2025-03-31 $16,256,226 554,820
2024-12-31 $16,971,367 516,475
2024-09-30 $23,654,709 532,404
2024-06-30 $29,245,450 678,234
2024-03-31 $10,588,797 362,134
2023-12-31 $4,821,098 216,484
2023-09-30 $3,917,430 158,280
2023-06-30 $2,714,755 95,860
2023-03-31 $2,346,293 102,146
2022-12-31 $4,655,607 165,798
2022-09-30 $8,237,709 291,291
2022-06-30 $6,128,209 276,419
2022-03-31 $873,300 30,000
2022-03-31 $1,471,306 50,543
2021-12-31 $3,742,775 113,866
2021-12-31 $986,100 30,000
2021-09-30 $6,495,797 140,754
2021-06-30 $1,178,692 21,388
2021-03-31 $4,459,527 86,358
2020-12-31 $8,060,679 186,030
2020-09-30 $11,748,450 335,670
2020-06-30 $13,907,153 260,044
2020-03-31 $3,753,784 105,800
2020-03-31 $8,064,710 227,303